Analyst Consensus ?
ConsensusHold36 ratings
Bullish1233.3%
Neutral2261.1%
Bearish25.6%
FN2 Earnings Intelligence
Archer-Daniels-Midland Company analyst ratings
Archer-Daniels-Midland Company (ADM) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$77.51Current
$50Low
$73.83Average
$100High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 28, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| JP Morgan | Underweight | Underweight | Maintain | Oct 12, 2026 |
| UBS | Buy | Buy | Maintain | Aug 17, 2026 |
| Morgan Stanley | Equal Weight | Underweight | Upgrade | Aug 5, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Aug 5, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Aug 5, 2026 |
| Jefferies | Hold | Hold | Maintain | Apr 6, 2026 |
| B of A Securities | Underperform | Neutral | Downgrade | May 8, 2025 |
| Citigroup | Neutral | Neutral | Maintain | Apr 15, 2025 |
| Goldman Sachs | Neutral | Neutral | Maintain | Jan 23, 2024 |
| Stifel | Hold | Buy | Downgrade | Jan 22, 2024 |
| Roth MKM | Neutral | Buy | Downgrade | Jan 22, 2024 |
| Baird | Neutral | Outperform | Downgrade | Jan 22, 2024 |
| Stephens & Co. | Equal Weight | Equal Weight | Maintain | Oct 25, 2023 |
| Argus Research | Buy | Buy | Maintain | Aug 1, 2023 |
| Wolfe Research | Outperform | Outperform | Maintain | Aug 12, 2022 |
| Credit Suisse | Neutral | Neutral | Maintain | Apr 27, 2022 |
| RBC Capital | Outperform | Outperform | Maintain | Jan 27, 2021 |
| Seaport Global | Buy | Buy | Maintain | Jul 28, 2020 |
| Monness, Crespi, Hardt | Neutral | Sell | Upgrade | Mar 2, 2020 |
| Monness Crespi Hardt | Neutral | Sell | Upgrade | Mar 2, 2020 |
| Buckingham Research | Buy | Buy | Maintain | Jul 19, 2019 |
| Stifel Nicolaus | Buy | Buy | Maintain | Apr 30, 2019 |
| Argus | Buy | Hold | Upgrade | Nov 8, 2018 |
| Buckingham | Buy | Buy | Maintain | Aug 1, 2018 |
| PiperJaffray | Neutral | Neutral | Maintain | Dec 14, 2016 |
| Macquarie | Outperform | Outperform | Maintain | Aug 29, 2016 |
| BB&T Capital | Hold | Hold | Maintain | Jul 12, 2016 |
| Standpoint Research | Hold | Buy | Downgrade | Apr 28, 2016 |
| Bank of America | Neutral | Buy | Downgrade | Mar 7, 2016 |
| Vertical Research | Hold | Hold | Maintain | Jul 7, 2015 |
| Miller Tabak | Buy | Hold | Upgrade | Jul 7, 2014 |
| Scotiabank | Sector Outperform | Sector Perform | Upgrade | Feb 5, 2014 |
| Standpoint | Hold | Buy | Downgrade | Feb 13, 2013 |
| Topeka Capital | Hold | Hold | Maintain | Aug 1, 2012 |
| Topeka | Hold | Hold | Maintain | Aug 1, 2012 |
| Deutsche Bank | Hold | Hold | Maintain | May 2, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $77.51. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Coker Palmer | Thomas Palmer | $75 | $80.5 | -3.2% | Oct 12, 2026 |
| Barclays | Benjamin Theuer | $90 | $79.87 | +16.1% | Aug 5, 2026 |
| Morgan Stanley | Steven K Haynes | $79 | $79.87 | +1.9% | Aug 5, 2026 |
| Morgan Stanley | Analyst unavailable | $60 | $85.11 | -22.6% | Jul 20, 2026 |
| UBS | Manav Gupta | $95 | $80.24 | +22.6% | Jun 15, 2026 |
| UBS | Analyst unavailable | $90 | $78.02 | +16.1% | May 7, 2026 |
| Morgan Stanley | Analyst unavailable | $58 | $76.61 | -25.2% | May 6, 2026 |
| Barclays | Analyst unavailable | $85 | $79.19 | +9.7% | May 6, 2026 |
| Barclays | Analyst unavailable | $68 | $67.52 | -12.3% | Feb 19, 2026 |
| BMO Capital | Andrew Strelzik | $63 | $67.39 | -18.7% | Feb 4, 2026 |
| Morgan Stanley | Steven Haynes | $50 | $60.2 | -35.5% | Dec 16, 2025 |
| Coker Palmer | Thomas Palmer | $59 | $60.12 | -23.9% | Nov 4, 2025 |
| Coker Palmer | Thomas Palmer | $64 | $62.7 | -17.4% | Apr 3, 2024 |
| BMO Capital | Andrew Strelzik | $60 | $58.27 | -22.6% | Mar 13, 2024 |
| Wolfe Research | Sam Margolin | $74 | $58.27 | -4.5% | Mar 13, 2024 |
| Goldman Sachs | Adam Samuelson | $64 | $58.27 | -17.4% | Mar 13, 2024 |
| Stifel Nicolaus | Vincent Anderson | $58 | $57.07 | -25.2% | Mar 12, 2024 |
| CFRA | Arun Sundaram | $67 | $57.07 | -13.6% | Mar 12, 2024 |
| Barclays | Benjamin Theurer | $60 | $54.81 | -22.6% | Mar 11, 2024 |
| Wolfe Research | Sam Margolin | $117 | $84.14 | +50.9% | Aug 12, 2022 |
| Credit Suisse | Analyst unavailable | $92 | $90 | +18.7% | Apr 27, 2022 |
| Barclays | Benjamin Theuer | $95 | $92.18 | +22.6% | Apr 22, 2022 |
| Bank of America Securities | Steve Byrne | $100 | $94.46 | +29.0% | Apr 19, 2022 |
| Stifel Nicolaus | Vincent Anderson | $100 | $94.57 | +29.0% | Apr 11, 2022 |
| Stephens | Ben Bienvenu | $67 | $62.71 | -13.6% | Oct 12, 2021 |
| Credit Suisse | Robert Moskow | $60 | $60.46 | -22.6% | Apr 27, 2021 |
Track every rating change on ADM the moment it posts. Free to start.
Start freeGet the ADM recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.